Pfizer's animal health unit, Zoetis, soars in IPO
Among its innovations, as part of Pfizer, the company created an injectable medicine for common bacterial skin infections in dogs and cats, Alaix said in an interview. The one shot spared pet owners the chore of forcing pills down the throat of their dog or cat three times a day, often for weeks, as required with older drugs. It also developed the first Lyme disease vaccine for dogs and a new vaccine to combat Hendra virus, which infects horses and can be transferred to humans.
Like Pfizer and other makers of medicines for people, Zoetis plans to expand in emerging markets such as China to increase growth.
Zoetis is currently based in Madison, N.J., at a campus shared with other Pfizer businesses, but Alaix said it will relocate at some point within New Jersey.
Pfizer shares rose 35 cents, or 1.3 percent, to end at $27.63.
AP Business Writer Tom Murphy in Indianapolis contributed to this story.
News Photo Galleriesview all
- 83533Oklahoma tornadoes: The 'Big Dog,' the little boy and the hug that triumphs over tragedy
- 16617OKC Thunder: Kevin Durant tours Moore, meets with residents
- 12334Oklahoma tornadoes: ‘All I could do was sit there and hold her'
- 12075Clippers' Donald Sterling hints coach let go to keep Chris Paul
- 11110Oklahoma tornado: Names of dead released; missing individuals located
- 9568Oklahoma tornadoes: Red Cross text donations not designated for Oklahoma
- 8849How to help tornado victims